Development of immunotherapies is becoming more prevalent for treatment of diseases, such as cancer, infections, and autoimmune disorders. While biochemical assays can clearly identify inhibitors of protein-protein interactions or protein activity, cell-based assays can provide additional insight in the context of live cells.
We offer rapid and dependable cell-based assay screening services to find compounds and biologics that affect Immunotherapy-related cellular pathways. Our team of experts, using our in-house developed cell-based assay kits, can provide:
Development of immunotherapies is becoming more prevalent for treatment of diseases, such as cancer, infections, and autoimmune disorders. While biochemical assays can clearly identify inhibitors of protein-protein interactions or protein activity, cell-based assays can provide additional insight in the context of live cells.
We offer rapid and dependable cell-based assay screening services to find compounds and biologics that affect Immunotherapy-related cellular pathways. Our team of experts, using our in-house developed cell-based assay kits, can provide:
Screening for activity
Compare potency with IC50 screens
Answer your questions and guide your project in a timely manner
Deliver detailed results promptly and on time
If follow-up studies are required, we can provide the same active proteins as the ones used in our assays.
Note: Not all targets will have a commercially available reference control. Please inquire with our team if you need to furnish your own controls for specific targets.